<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 9">
<meta name=Originator content="Microsoft Word 9">
<link rel=File-List href="./Page1_files/filelist.xml">
<link rel=Edit-Time-Data href="./Page1_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>jennifer</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>jennifer</o:LastAuthor>
  <o:Revision>28</o:Revision>
  <o:TotalTime>461</o:TotalTime>
  <o:Created>2003-09-19T09:12:00Z</o:Created>
  <o:LastSaved>2003-10-02T19:09:00Z</o:LastSaved>
  <o:Pages>3</o:Pages>
  <o:Words>826</o:Words>
  <o:Characters>4709</o:Characters>
  <o:Company>EMBL-EBI</o:Company>
  <o:Lines>39</o:Lines>
  <o:Paragraphs>9</o:Paragraphs>
  <o:CharactersWithSpaces>5782</o:CharactersWithSpaces>
  <o:Version>9.4402</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:Zoom>150</w:Zoom>
 </w:WordDocument>
</xml><![endif]-->
<style>
<!--
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:16.0pt;
	font-family:Arial;
	mso-font-kerning:16.0pt;}
h2
	{mso-style-next:Normal;
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:center;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:14.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Times New Roman";
	font-weight:normal;}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:595.3pt 841.9pt;
	margin:72.0pt 90.0pt 72.0pt 90.0pt;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1030"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-GB link=blue vlink=purple style='tab-interval:36.0pt'>

<div class=Section1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
 o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
 stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_s1026" type="#_x0000_t75" alt=""
 href="http://www.ebi.ac.uk/interpro/index.html" title="To InterPro database"
 style='position:absolute;margin-left:0;margin-top:0;width:113.5pt;height:36.5pt;
 z-index:1;mso-position-horizontal:left;mso-position-horizontal-relative:text;
 mso-position-vertical:top;mso-position-vertical-relative:line' o:allowoverlap="f"
 o:button="t">
 <v:fill o:detectmouseclick="t"/>
 <v:imagedata src="http://web7-node1.ebi.ac.uk:9130/interpro/images/interpro_logo.jpeg"/>
 <w:wrap type="square"/>
</v:shape><![endif]--><![if !vml]><a
href="http://www.ebi.ac.uk/interpro/index.html"><img border=0 width=151
height=49
src="http://web7-node1.ebi.ac.uk:9130/interpro/images/interpro_logo.jpeg"
align=left hspace=12 title="To InterPro database" v:shapes="_x0000_s1026"></a><![endif]><a
href="http://www.ebi.ac.uk/interpro/index.html"></a><a
href="http://www.ebi.ac.uk/interpro/index.html"></a><a
href="http://www.ebi.ac.uk/interpro/index.html"></a><a
href="http://www.ebi.ac.uk/interpro/index.html"></a><span style='font-size:
36.0pt;mso-bidi-font-size:12.0pt;color:navy'><o:p></o:p></span></p>

<h1 align=center style='text-align:center'><span style='font-size:36.0pt;
mso-bidi-font-size:16.0pt;color:navy'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></h1>

<h1 align=center style='text-align:center'><span style='font-size:36.0pt;
mso-bidi-font-size:16.0pt;color:navy'>Trypsin and Chymotrypsin<o:p></o:p></span></h1>

<h2>By Jennifer McDowall</h2>

<p class=MsoNormal><span style='font-size:14.0pt;mso-bidi-font-size:12.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=MsoNormal>&nbsp;<a
href="http://www.rcsb.org/pdb/static.do?p=education_discussion/molecule_of_the_month/pdb46_1.html"
title="link to structural features of Trypsin/Chymotrypsin"><span
style='text-decoration:none;text-underline:none'><!--[if gte vml 1]><v:shape
 id="_x0000_i1025" type="#_x0000_t75" style='width:90pt;height:20.25pt'>
 <v:imagedata src="./Page1_files/image001.jpg" o:title="PDB_logo"/>
</v:shape><![endif]--><![if !vml]><img border=0 width=120 height=27
src="./Page1_files/image002.jpg" v:shapes="_x0000_i1025"><![endif]></span></a></p>

<p class=MsoNormal><u><span style='font-size:10.0pt;mso-bidi-font-size:12.0pt'><a
href="http://www.rcsb.org/pdb/static.do?p=education_discussion/molecule_of_the_month/pdb46_1.html"
title="link to structural features of trypsin/chymotrypsin">to view
trypsin/chymotrypsin structure</a><o:p></o:p></span></u></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span>Digestive
enzymes, synthesized and secreted by pancreatic acinar cells, breakdown the
foods that we eat:<span style="mso-spacerun: yes">  </span>starches (amylases),
fats (lipases) and proteins (proteases).<span style="mso-spacerun: yes"> 
</span>Pancreatic proteases have long been used in medicine both diagnostically
and therapeutically for pancreatic disease, and more recently for their
involvement in cancer metastases.<span style="mso-spacerun: yes"> 
</span>Proteases represent a diverse array of enzymes that act on the peptide
bonds within proteins.<span style="mso-spacerun: yes">  </span>They can be
divided into discreet protein families that differ with respect to structure
and catalytic type, including serine, threonine, cysteine, aspartic and metallo
proteases.<span style="mso-spacerun: yes">  </span>The two proteases trypsin
and chymotrypsin are grouped into the serine protease family.<span
style="mso-spacerun: yes">  </span></p>

<h1><span style='color:navy'>Trypsin and chymotrypsin, serine protease
digestive enzymes.<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span>Trypsin and
chymotrypsin, like most proleotytic enzymes, are synthesized as inactive
zymogen precursors (trypsinogen and chymotrypsinogen) to prevent unwanted
destruction of cellular proteins, and to regulate when and where enzyme
activity occurs.<span style="mso-spacerun: yes">  </span>The inactive zymogens
are secreted into the duodenum, where they travel the small and large
intestines prior to excretion.<span style="mso-spacerun: yes">  </span>Zymogens
also enter the bloodstream, where they can be detected in serum prior to
excretion in urine.<span style="mso-spacerun: yes">  </span>Zymogens are
converted to the mature, active enzyme by proteolysis to split off a
pro-peptide, either in a subcellular compartment or in an extracellular space
where they are required for digestion.</p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span>Trypsin and
chymotrypsin are structurally very similar, although they recognise different
substrates.<span style="mso-spacerun: yes">  </span>Trypsin acts on lysine and
arginine residues, while chymotrypsin acts on large hydrophobic residues such
as tryptophan, tyrosine and phenylalanine, both with extraordinary catalytic
efficiency.<span style="mso-spacerun: yes">  </span>Both enzymes have a
catalytic triad of serine, histidine and aspartate within the S1 binding
pocket, although the hydrophobic nature of this pocket varies between the two,
as do other structural interactions beyond the S1 pocket.<span
style="mso-spacerun: yes">  </span></p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span>The human
pancreas secretes three isoforms of trypsinogen:<span style="mso-spacerun:
yes">  </span>cationic (trypsinogen-1), anionic (trypsinogen-2) and
mesotrypsinogen (trypsinogen-3).<span style="mso-spacerun: yes"> 
</span>Cationic and anionic trypsins are the major isoforms responsible for
digestive protein degradation, occurring in a ratio of 2:1, while
mesotrypsinogen accounts for less than 5% of pancreatic secretions.<span
style="mso-spacerun: yes">  </span>Mesotrypsin is a specialised protease known
for its resistance to trypsin inhibitors.<span style="mso-spacerun: yes"> 
</span>It is thought to play a special role in the degradation of trypsin
inhibitors, possibly to aid in the digestion of inhibitor-rich foods such as
soybeans and lima beans.<span style="mso-spacerun: yes">  </span>An
alternatively spliced mesotrypsinogen in which the signal peptide is replaced
with a different exon 1 is expressed in the human brain; the function of this
brain trypsinogen is unknown.</p>

<p class=MsoNormal><span style="mso-spacerun: yes">  </span><span
style='mso-tab-count:1'>          </span>There are two isoforms of pancreatic
chymotrypsin, A and B, which are known to cleave proteins selectively at
specific peptide bonds formed by the hydrophobic residues tryptophan,
phenylalanine and tyrosine.</p>

<h1><span style='color:navy'>The need for inhibitors<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span>Proteases
perform many beneficial functions that are essential to life, but uncontrolled
they can be dangerous.<span style="mso-spacerun: yes">  </span>Protease inhibitors
are used as the major form of control once the protease has been
activated.<span style="mso-spacerun: yes">  </span>In higher organisms, there
is a delicate balance between proteases and their natural inhibitors to help
control the activation and catabolism of many intra- and extra-cellular
proteins.<span style="mso-spacerun: yes">  </span>In mammals, the bloodstream
is a major carrier for many glycoproteins that act as protease inhibitors.<span
style="mso-spacerun: yes">  </span>Protease inhibitors use a reactive site
peptide bond to serve as a substrate for various proteases, forming very stable
complexes where the inhibitor peptide bond is hydrolysed by the protease
extremely slowly, thereby effectively removing the protease from
circulation.<span style="mso-spacerun: yes">  </span>There are at least
eighteen families of protease inhibitors, all of which share a common
conformation surrounding the reactive site peptide bond, even though they
differ in their global structure.<span style="mso-spacerun: yes">  </span>Some
members only hydrolyse trypsin, such as chicken ovomucoid, while others
hydrolyse both trypsin and chymotrypsin using different inhibitory domains,
such as turkey ovomucoid.</p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span>Protease
inhibitors are ubiquitous in nature.<span style="mso-spacerun: yes"> 
</span>They are widely distributed in plant seeds, particularly in
legumes.<span style="mso-spacerun: yes">  </span>The presence of these
inhibitors in seeds acts as a feeding deterrent, especially in insects where
they inhibit midgut proteases.<span style="mso-spacerun: yes">  </span>Inhibitors
can deter other animals as well; isolated soybean inhibitors have been found to
cause enlargement of the pancreas in certain species, such as rat and
mouse.<span style="mso-spacerun: yes">  </span>Many bacterial species produce
protease inhibitors that help them to survive the digestive processes of the
gut, such as ecotin in Escherichia coli, which is effective against several
different pancreatic proteases because of its flexibility. </p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span>Protease
inhibitors can have nutritional value as well.<span style="mso-spacerun: yes"> 
</span>The Bowman-Birk inhibitor (BBI) from soybean may play a role in the
prevention of tumourigenesis.<span style="mso-spacerun: yes">  </span>BBI is
also an effective inhibitor of nephrotoxicity induced by the antibiotic
gentamicin.</p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span></p>

<h1 align=center style='text-align:center'>Next: <a href="Page2.htm">Pancreatitis,
when control fails</a></h1>

</div>

</body>

</html>
